Home > Press > NanoInk Releases Two New Nanoscale Applications in Biology for the NLP 2000 System
Abstract:
NanoInk, Inc.®, a global leader in nanolithography, announced today that it expanded the range of nanoscale applications for biology with the recent launch of two new Application Notes. NanoInk's NanoFabrication Systems Division instruments, most notably the NLP 2000 System, have now been proven to enable applications related to micropatterning of polyethylene glycol (PEG)-based hydrogel and UV-curable polymer.
These new capabilities broaden even further the applicability of the NLP 2000 System for biological sciences. Earlier Application Notes described the benefits of using NanoInk's platform to functionalize biosensors, pattern functional hydrogels and print multiplexed protein arrays.
Launched in 2009 as a tool for bioscience research, the NLP 2000 System is a simple, user-friendly desktop nanolithography platform. The system leverages patented Dip Pen Nanolithography® (DPN®) technology to deposit sub-cellular-scale features of a wide variety of materials with nanoscale registry, all under ambient conditions. With the addition of two new Application Notes to its portfolio of biological research support materials, NanoInk continues to serve as a true partner to the life science community.
"The first of the new Application Notes demonstrates successful use of the NLP 2000 System for micropatterning PEG-based hydrogels," said Tom Warwick, NanoInk's general manager of sales and marketing. "Hydrogels are three-dimensional cross-linked polymer networks that have physical characteristics similar to those of natural tissues. The versatility of PEG chemistry and the excellent biocompatibility of PEG-based hydrogels have been instrumental in hydrogel advances related to controlled material release, directed cellular function, tissue engineering, and regenerative medicine applications. NanoInk has developed a consistent and reproducible methodology for directly depositing hydrogel precursors at defined locations on a surface and subsequently polymerizing these precursors to form PEG-based hydrogels."
The second new bioscience Application Note validates the utility of the NLP 2000 System for printing UV-curable polymers. Features generated by the NLP 2000 System have sub-cellular dimensions, so polymer arrays can be used to study cell/substrate interactions at the single cell level. Micro-patterned polymers are also useful in tissue engineering, lab-on-a-chip, flexible circuit and microlens applications. With DPN's ability to generate arrays that cover millimeter-scale areas with nanometer resolution and precision, the NLP 2000 System has been proven to print homogeneous and highly reliable polymer patterns onto smooth substrates like glass and silicon wafers.
NanoInk is dedicated to developing and supporting a wide range of biological applications for the NLP 2000 System. The latest two Application Notes further confirm this commitment. A full list of applications notes is available at: www.nanoink.net/biomaterials/literature.html#notes.
Please visit NanoInk's new Web site at www.nanoink.net or call (847) 679-8807 for more information on the NanoFabrication Systems Division, the NLP 2000 System, and related Application Notes.
####
About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop.
Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 250 patents and applications filed worldwide and licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., visit www.nanoink.net.
NanoInk, the NanoInk logo, Dip Pen Nanolithography, DPN, NanoEncryption, NanoGuardian, NanoProfessor, NanoStem are trademarks or registered trademarks of NanoInk, Inc.
For more information, please click here
Contacts:
Joshua Taustein
Dresner Corporate Services
(312) 780-7219
David Gutierrez
Dresner Corporate Services
(312) 780-7204
Copyright © NanoInk
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||